You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Lilly declares Q3 2026 dividend
23 June 2026 -

US pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Monday that its board of directors has declared a dividend of USD1.73 per share of common stock for the third quarter of 2026.

This amount is unchanged from the previous quarterly dividend.

The Q3 dividend is payable on 10 September 2026, to shareholders of record at the close of business on 14 August 2026.

Login
Username:

Password:


Related Headlines

Convatec launches co-branded eakin freeseal ostomy seal in North America

UHS to acquire Talkspace for USD835m

Abbott announces quarterly dividend

Aptamer Optimer technology integrated into Twist Bioscience TrueAmp Library Preparation Kit

Alvotech reports positive PK study results for AVT80 biosimilar candidate

Inspiration Healthcare secures US purchasing agreement to drive Airon growth

West to sell SmartDose 3.5mL On-Body Delivery System rights to AbbVie for USD112.5m

Citius Pharmaceuticals reports full-year financial results

Sanofi receives FDA complete response letter for tolebrutinib in progressive MS

Abbott announces quarterly common dividend increase

Amgen announces Q1 2026 dividend

Eli Lilly announces Q1 2026 dividend

Oxford Nanopore and bioMérieux introduce AmPORE-TB for rapid tuberculosis resistance characterisation

Amgen announces Q4 2025 dividend

Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026